newsfilter
← Latest News
GlobeNewswire·

Aileron Therapeutics to Host Key Opinion Leader Event on February 15, 2024

WALTHAM, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Aileron Therapeutics, Inc. ("Aileron") (NASDAQ:ALRN), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet